Research Study

Phosphodiesterase inhibitor, ibudilast alleviates core behavioral and biochemical deficits in the prenatal valproic acid exposure model of autism spectrum disorder.

📅 2023 🔗 DOI: 10.1016/j.brainres.2023.148443
Citation
Sandhu A., Rawat K., Gautam V., Sharma A., Kumar A. et al. (2023). Phosphodiesterase inhibitor, ibudilast alleviates core behavioral and biochemical deficits in the prenatal valproic acid exposure model of autism spectrum disorder.. Brain Res. DOI: 10.1016/j.brainres.2023.148443
View Full Study →

Abstract

Abstract not available. See citation for source.

Disclaimer: This research summary is for educational purposes only. Always consult with a healthcare professional before making decisions based on scientific research.